Post-transplant survival in hepatitis B-infected patients. Later studies have shown comparable patient and graft survival in hepatitis B surface antigen (HBsAg)-positive patients compared with HBsAg-negative patients. There may only be a slight 3% to 4% difference overall (in favor of HBsAg-negative patients) in long-term graft and patient survival. (Data from Pirson and coworkers , Hillis and coworkers , Touraine and coworkers , Dhar and coworkers , Roy and coworkers , and Pfaff and Blanton .)
CHRONIC HEPATITIS B INFECTION IN HBsAg-POSITIVE RENAL TRANSPLANT RECIPIENTS: RESULTS OF LIVER BIOPSIES PERFORMED PERITRANSPLANT AND A MEDIAN OF 66 MONTHS LATER
Was this article helpful?